XU; Yongxiang

Patent Applications and Registrations

Patent applications and USPTO patent grants for XU; Yongxiang.The latest application filed is for "method for synthesis of roxadustat and intermediate compounds thereof".

Company Profile

2.12.13

XU; Yongxiang - Nanjing CN
Xu; Yongxiang - Jiangsu CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method For Synthesis Of Roxadustat And Intermediate Compounds Thereof App 20200385355 - XU; Yongxiang	2020-12-10
Methods for synthesizing 3-(substituted dihydroisoindolinone-2-yl)-2, 6-dioxopiperidine, and intermediates thereof Grant 9,522,899 - Yan , et al. December 20, 2	2016-12-20
Methods for synthesizing 3-(substituted dihydroisoindolinone-2-yl)-2, 6-dioxopiperidine, and intermediates thereof App 20150284359 - Yan; Rong ; et al.	2015-10-08
Methods for synthesizing 3-(Substituted Dihydroisoindolinone-2-YI)-2, 6-Dioxopiperidine, and intermediates thereof App 20150284329 - Yan; Rong ; et al.	2015-10-08
Synthesis process of dasatinib and intermediate thereof Grant 9,108,954 - Yan , et al. August 18, 2	2015-08-18
Polymorph of 3-(substituteddihydroisoindolinone-2-yl)-2,6-dioxopiperidine, and pharmaceutical compositions thereof Grant 9,101,620 - Yan , et al. August 11, 2	2015-08-11
Methods for synthesizing 3-(substituted dihydroisoindolinone-2-yl)-2, 6-dioxopiperidine, and intermediates thereof Grant 9,085,530 - Yan , et al. July 21, 2	2015-07-21
Polymorphs of Dasatinib, preparation methods and pharmaceutical compositions thereof Grant 8,884,013 - Yan , et al. November 11, 2	2014-11-11
Pharmaceutical formulations comprising voriconazole and processes for preparation thereof Grant 8,586,592 - Xu November 19, 2	2013-11-19
Synthesis Process Of Dasatinib And Intermediate Thereof App 20130030177 - Yan; Rong ; et al.	2013-01-31
Novel and Highly Stereoselective Process for Preparing Gemcitabine and Intermediates Thereof App 20130018181 - XU; Yongxiang ; et al.	2013-01-17
Polymorphs Of Dasatinib, Preparation Methods And Pharmaceutical Compositions Thereof App 20120309968 - Yan; Rong ; et al.	2012-12-06
Highly stereoselective process for preparing gemcitabine and intermediates thereof Grant 8,324,373 - Xu , et al. December 4, 2	2012-12-04
Polymorph Of 3-(substituteddihydroisoindolinone-2-yl)-2,6-dioxopiperidine, And Pharmaceutical Compositions Thereof App 20120203005 - Yan; Rong ; et al.	2012-08-09
Methods for Synthesizing 3-(Substituted Dihydroisoindolinone-2-YL)-2, 6-Dioxopiperidine, and Intermediates Thereof App 20120077982 - Yan; Rong ; et al.	2012-03-29
Pharmaceutical Formulations Comprising Voriconazole and Processes for Preparation Thereof App 20110257197 - Xu; Yongxiang	2011-10-20
Novel and Highly Stereoselective Process for Preparing Gemcitabine and Intermediates Thereof App 20100179314 - Xu; Yongxiang ; et al.	2010-07-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.